Asia Pacific Immunodiagnostics Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2030

Analysis - by Product (Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others), By Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)

No. of Pages: 225
Report Code: BMIRE00027857
Category: Life Sciences
Asia Pacific Immunodiagnostics Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Immunodiagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Immunodiagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Immunodiagnostics Market Regional Analysis

6.2 Asia Pacific Immunodiagnostics Market Revenue 2021-2030 (US$ Million)
6.3 Asia Pacific Immunodiagnostics Market Forecast Analysis

7. Asia Pacific Immunodiagnostics Market Analysis – by Product

7.1 Enzyme-Linked Immunosorbent Assays
  • 7.1.1 Overview
  • 7.1.2 Enzyme-Linked Immunosorbent Assays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
7.2 Chemiluminescence Immunoassays
  • 7.2.1 Overview
  • 7.2.2 Chemiluminescence Immunoassays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
7.3 Radioimmunoassays
  • 7.3.1 Overview
  • 7.3.2 Radioimmunoassays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

8. Asia Pacific Immunodiagnostics Market Analysis – by Clinical Indication

8.1 Infectious Diseases
  • 8.1.1 Overview
  • 8.1.2 Infectious Diseases: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.2 Hepatitis+HIV
  • 8.2.1 Overview
  • 8.2.2 Hepatitis+HIV: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.3 Endocrinology
  • 8.3.1 Overview
  • 8.3.2 Endocrinology: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.4 Gastrointestinal
  • 8.4.1 Overview
  • 8.4.2 Gastrointestinal: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
8.5 Metabolics
  • 8.5.1 Overview
  • 8.5.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

9. Asia Pacific Immunodiagnostics Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Clinics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9.3 Diagnostic Laboratories
  • 9.3.1 Overview
  • 9.3.2 Diagnostic Laboratories: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)
9.4 Academic & Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Academic & Research Institutes: Asia Pacific Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

10. Asia Pacific Immunodiagnostics Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific
  • 10.2.1 Asia Pacific Immunodiagnostics Market Breakdown, by Key Country, 2024 and 2030 (%)
  • 10.2.1.1 Asia Pacific Immunodiagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 China: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.1.1 China: Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.2.1.1.2 China: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.2.1.1.3 China: Asia Pacific Immunodiagnostics Market Breakdown, by End User
  • 10.2.1.2 India: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.2.1 India: Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.2.1.2.2 India: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.2.1.2.3 India: Asia Pacific Immunodiagnostics Market Breakdown, by End User
  • 10.2.1.3 Japan: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.3.1 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.2.1.3.2 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.2.1.3.3 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by End User
  • 10.2.1.4 Australia: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.4.1 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.2.1.4.2 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.2.1.4.3 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by End User
  • 10.2.1.5 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 bioMerieux SA
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Danaher Corp
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 DiaSorin SpA
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 PerkinElmer Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Siemens Healthcare GmbH
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Svar Life Science AB
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Asia Pacific Immunodiagnostics Market

  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corp
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare GmbH
  • Svar Life Science AB
  • Thermo Fisher Scientific Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)